Aurealis Pharma is a Swiss-Finnish biopharmaceutical company with a technology platform facilitating combination therapy embedded in one single product that can be administered in a safe, efficient and cost-effective way. Safe food-grade lactic acid bacteria release multiple therapeutic human proteins locally in diseased tissue. Our first products are immuno-therapeutics to treat patients with chronic inflammatory wounds and cancer indications.

info@artidis.com | https://www.aurealispharma.com/